The Effect of Dolutegravir on Obstetrical Outcomes Among Women Living with HIV: A Retrospective Cohort Study

This retrospective cohort study evaluates the association between dolutegravir-based antiretroviral therapy and obstetrical outcomes among women living with HIV. Using clinical data from HIV treatment programs, the authors examine maternal and neonatal outcomes including preterm birth, low birth weight, and pregnancy complications. The findings contribute to ongoing evidence regarding the safety and effectiveness of dolutegravir use during pregnancy and inform treatment guidelines for women living with HIV in resource-constrained settings.